Rhythm Pharmaceuticals, Inc.
RYTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001649904
In the last 90 days, Rhythm Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $8.55B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Rhythm Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 126 | 116 | −10 |
| Shares | 60.3M | 66.2M | +5.88M (+9.7%) |
| Value | $1.08B | $1.09B | +$15.7M (+1.5%) |
New holders (28)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (38)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.